Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors while in the central nervous program, conolidine modulates alternate molecular targets. A Science Improvements study uncovered that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR